PROPOSED CANDIDATE MATERIAL FOR A WHO PANEL FOR SEROLOGICAL REFERENCE RESULTS OF THE FEASIBILITY STUDIES WITH SERA FROM TC I REGION RESULTS OF THE FEASIBILITY.

Slides:



Advertisements
Similar presentations
Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood 1. Médecins Sans Frontières.
Advertisements

TESTS USED IN BLOOD SCREENING French Blood Services (EFS)
Chagas Tests: Development and Standardization
CHAGAS DISEASE Overwiev Diagnosis Proposals for WHO Ref.Preparation Alejandro O. Luquetti Laboratório de Pesquisa em Doença de Chagas Hospital das Clínicas.
Preparation, characterization and establishment of a WHO International Biological Reference Preparation Dr Sjoerd Rijpkema Division of Bacteriology NIBSC.
WHO Consultation Meeting January 2009 Quality Control of Chagas diagnostics immunoassays: Assay characteristics and manufacturers reference panels.
Standardization of PCR for Trypanosoma cruzi detection
High Throughput Donor Plasma NAT Screening Assay Applied to Acute HIV Detection in a Public Health Setting December 5, 2007 Josh Goldsmith, Ph.D. National.
Development of a Panel for Dengue Virus Maria Rios, PhD CBER/FDA Blood Products Advisory Committee Meeting December 14, 2010.
CHAGAS DISEASE Serological Diagnosis and the humoral immune response after specific treatment Alejandro O. Luquetti & Anis Rassi Laboratório de Pesquisa.
WHO comparative evaluation of serologic assays for Chagas disease Journal Club April 2, 2009.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Primary HIV Infection: the CDC study Pragna Patel, MD MPH Medical Epidemiologist Behavioral and Clinical Surveillance Branch DHAP, CDC February 28, 2005.
HEV in Belgium: An import infection or an emerging viral zoonosis? I.Micalessi, I.Thomas, B. Brochier National Center of Viral Hepatitis Rue Juliette Wytsmanstraat.
Vironostika® HIV-1 Plus O Microelisa System
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
F. Kourgia, M. Vini, E. Zervou
Comparison of the Diagnostic Value of the Standard Tube Agglutination Test and the ELISA IgG and IgM in Patients with Brucellosis Presented by Dr. Md.
DEPARTMENT OF HEALTH RESEARCH INSTITUTE FOR TROPICAL MEDICINE Ebola Virus Disease Diagnosis Catalino S. Demetria, DVM.
C H I R O N Blood Testing Blood Products Advisory Committee 67th Meeting – September 14, 2000 Detection of HIV-1 p24 antigen positive donor specimens by.
ICBS Master Panels for Kit Evaluation: HCV, HBV, and HIV ( Howard A. Fields, Ph.D. Susan Diaz, MPH Division of Viral Hepatitis Centers.
FDA Guidance for Industry: Use of Serological Tests to Reduce the Risk of Transmission of Trypanosoma cruzi Infection in Whole Blood and Blood Components.
Prof. Musabaev E.I. Quality Control Systems for Hepatitis B and C diagnostics in Uzbekistan.
SOGAT Validation of HCV-RNA detection in small test pools on cadaveric samples Marco Koppelman #, Theo Cuypers #, Mirjam de Waal #, Maarten.
21th VHPB meeting on “Prevention of viral hepatitis in Italy: lessons learnt and the way forward” Catania, 7-8 november 2002 RESIDUAL RISK OF TRANSFUSION-
Ethical considerations on HIV and Syphilis research in indigenous communities in Peru Instituto Nacional de Salud Ministerio de Salud PERÚ Centro Nacional.
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk.
Detection of Dengue Virus RNA in Blood Donors from Honduras and Brazil with a Prototype Transcription-Mediated Amplification Assay.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Panbio Dengue ELISAs.
Yi-Chen Yang, Yu-Hsuan Chen, Show-Lan Chiu, Hwei-Fang Cheng Drug Biology Division, Bureau of Food and Drug Analysis Department of Health, Taiwan, ROC National.
1 Blood Systems Trypanosoma cruzi and Chagas Disease Studies and Potential Strategies for Targeted Testing of Donors Blood Products Advisory Committee.
SoGAT June 14, 2006 HCV-RNA and HIV-RNA detection in small test pools of cadaveric samples for viral safety of tissue transplants Maarten Koot#,
Comparison of the diagnostic value of STA test and ELISA IgG and IgM in patients with Brucellosis Mustafa Ertek, Halil Yzgi, Zulal Ozkart et al. Turk J.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
Blood Products & related Biologicals: SoGAT, 28 May 09 1 |1 | Dr Ana Padilla, Blood Products & related Biologicals Essential Medicines and Pharmaceutical.
Household Infestation Rates of Chagas Disease Vectors and Trypanosoma cruzi Prevalence in Southern Ecuador Stanton Jasicki Dr. Daniel Herman Dr. Mario.
Avidity determination of IgG in diagnosis of tick-born encephalitis Hana Zelená Jiří Januška Jan Raszka Virology department, National Reference Laboratory.
NUCLEIC ACID AMPLIFICATION TECHNOLOGY HCV-RNA / HBV-DNA / HIV-RNA testing blood and blood components for transfusion Italian External Quality Assessment.
Ad Hoc Disease Transmission Advisory Committee Fall 2014.
Issues Related to Implementation of Blood Donor Screening for Infection with Trypanosoma cruzi Presentation to BPAC April 26, 2007 Robert Duncan, PhD.
Update Rapid HIV Test Approval Requirements and Standards BPAC September 15, 2000 Kimber Poffenberger, Ph.D.
Dr. Gamaliel Gutiérrez Regional Dengue Program PAHO/WHO WDC
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
January 27, Paul Contestable Principal Scientist Ortho Clinical Diagnostics Second WHO Consultation: Development of a WHO Reference Panel for the.
Ad Hoc Disease Transmission Advisory Committee Fall 2014.
Blood Products Advisory Committee Meeting April 26, 2007 Ben Marchlewicz, Ph.D. PRISM R&D, Program Manager.
Country report for “Peste des Petits Ruminants(PPR).” Dr. Yousef S N S SH Al Azemi Head, Epidemiology & Zoonosis, Animal Health Department Public Authority.
Trypanosoma cruzi in southwest Georgia raccoons Berrien R. Waters and J. Mitchell Lockhart Department of Biology Valdosta State University Valdosta, Georgia.
Prevalence of hepatitis B and C viruses among human immunodeficiency virus infected children in Northern Nigeria. Pennap GRI, Yahuza, AJ and Abdulkarim,
Estimating Frequency of Travel to Endemic Areas Brian Custer, PhD, MPH Blood Systems Research Institute Blood Products Advisory Committee Meeting August.
Evaluation of Hepatitis B surveillance system in Armenia, 2014 AUTHORS Karine Gevorgyan Lusine Paronyan Shushan Sargsyan Artavazd Vanyan NCDC, Armenia.
1 Update on Study to Further Define the Incidence of T. cruzi Infection in the US Blood Donor Population Susan L. Stramer, PhD American Red Cross BPAC.
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
RESULTS Division of Arboviruses, Center for Immunology and Pathology, National Institute of Health, Korea Centers for disease control, Osong, Korea BACKGROUND.
Serologic markers and molecular epidemiology of HBV from an HIV infected cohort from Cameroon Tshifhiwa Magoro 1, Emmaculate Nongpang 2, Lufuno Mavhandu.
RETROVIRIDAE GENUS: ONCOVIRUS: HTLV-1 and HTLV-2 SPUMAVIRUS LENTIVIRUS: HIV-1 and HIV-2.
Proposed candidate materials and results of the feasibility studies for a WHO serological reference panel T.cruzi type II Márcia Otani Fundação Pró-Sangue.
Proposed Animal Study to Evaluate Simian Foamy Virus (SFV) Transmission by Blood Arifa S. Khan, Ph.D. DVP, OVRR, CBER, FDA BPAC, December 13, 2001.
Abbott HCV core Ag and HCV RNA Comparison Study
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Screening for Trypanosoma cruzi antibodies and Strongyloides stercoralis antibodies in migrants to Italy coming from endemic areas using four immunological.
Introduction Results Conclusions Methods
Peste des Petits Ruminant in KSA Ministry of Agriculture Kingdom of Saudi Arabia
Genetic sequencing pilot project in Latin America
Representation for the Americas
Evaluation of Candidate Standard XX (97/650)
NUCLEIC ACID AMPLIFICATION TESTING DETECTS HIV TRANSMISSION RISK IN SEROLOGICALLY- TESTED BLOOD DONOR UNITS. |Presented by Miss Shemau Muniru| Authors:
Representation for the Americas
Presentation transcript:

PROPOSED CANDIDATE MATERIAL FOR A WHO PANEL FOR SEROLOGICAL REFERENCE RESULTS OF THE FEASIBILITY STUDIES WITH SERA FROM TC I REGION RESULTS OF THE FEASIBILITY STUDIES WITH SERA FROM TC I REGION DR. CARMEN GUZMAN BRACHO Instituto de Diagnóstico y Referencia Epidemiológicos

PROJECT ORGANIZATION WHO, JULY –Develop a reference panel. –Commitment to collect and evaluate sera from TcI region accepted. National Center of Blood Transfusion, Aug –Selection of a Blood Transfusion Center. State Center of Blood Transfusion in Hidalgo, Sep –Participate in the writing of the Protocol, responsibilities and consent form. –Make contact with donors in home towns. –Transfer donors to Pachuca City for blood collections. –Collect Plasma units. Institute of Epidemiological Diagnosis and Reference –Coordinate the Project. –Select blood donors. –Evaluate individual sera samples and mixtures. –Analyze results. –Deliver positive and negative plasma units to Fundacao Pró-Sangre Hemocentro de Sao Paulo, Jun 2008.

MAIN CONDITIONS Mexican donors. Final volume: 1.5 – 3.0 L Since ethical and operative problems with a single donor raise, it is suggested that a pool of positive sera is more realistic. Negative sera are necessary to dilute reactive samples. All samples must be negative to viral markers (HIV, HBV, HCV) and syphilis.

HIDALGO STATE LABORATORY OF PUBLIC HEALTH HIDALGO STATE CENTER OF BLOOD TRANSFUSION SELECTION OF CANDIDATES DATA BASE CONFIRMED CASES –SCREENING TEST FOR POSITIVES ELISA (BIOKIT) –CONFIRMATION TESTS OF POSITIVES ELISA recombinant (BIOKIT) ELISA crude (INTERBIOL) HAI (INTERBIOL) IFI (InDRE)

INITIAL RESULTS FOR SELECTED CANDIDATES 10 mL of serum from 10 candidates were collected to confirm tests results

FINAL RESULTS FOR SELECTED CANDIDATES According to the OD/CO index, 6 serum samples were selected to evaluate reactivity of mixtures ReactivityOD/CO LOW2.81 – 3.55 MEDIUM4.19 – 5.81 HIGH7.74 – 8.39

COMPOSITION OF MIXTURES Individual sera data Mixtures data

REACTIVITY OF THE MIXTURES TWO REPLICATES PER PLATE TWO RUNNINGS REACTIVITY IN ELISA MEXICAN CRUDE ANTIGEN WITH SERA MIXTURES FROMT. cruzi INFECTED MEXICAN INDIVIDUALS DILUTION OD/CO MEZCLA1MEZCLA2MEZCLA3MEZCLA4 Low reactivity

REACTIVITY OF SERA MIXTURES BY DILUTION WIDTH CI 95% = 0.68 WIDTH CI 95% = 1.37

WHEN ADDING ANOTHER SERUM TO THE MIXTURE….. Mixture = 2 high + 1 medium + 1 low

MEXICAN SERA BELONG TO T. cruzi I 1.54 of 56 isolates studied coming from 8 provinces of the Mexican Republic were TcI. 2.Given the prevalence of seropositive individuals and of disease cases in the country, T. cruzi I stocks can be considered the primary agents of Chagas’ disease in Mexico –Bosseno et al. Predominance of Trypanosoma cruzi lineage I in Mexico. J Clin Microbiol feb;40(2): –Sánchez-Guillén et al. Trypanosoma cruzi strains isolated from human, vector, and animal reservoir in the same endemic region in Mexico and typed as T. cruzi I, discrete typing unit 1 exhibit considerable biological diversity.Mem Inst Oswaldo Cruz Sep;101(6): PROTOCOL NUMBERREACTIVITY DATA FOR TRACEABILITY CHAIN No InDREFOLIO CETSUNIT NUMBERAGE 3HIGH MEDIUM SERA SENT TO BRAZIL

Complementary tests

CONCLUSIONS Mixture 1 and 2 turned out to be the best. Optimal dilution was found at 1:10. We got 200 mL of plasma from both donors included in mixture 2. Plasma units were sent to Brazil (M. Otani) coded and Finally, 10 plasma units of seronegative individuals to prepare final dilution were delivered to Brazil.

MANY THANKS!